Grow Funds, an investment Advisor, released its Q1 2026 investor letter for "GROW Small Cap Equity Long/Short Fund". A copy of the letter can be downloaded here . In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index's –2.80%, HFRI Equity Hedge Index's -0.24%, and the HFRI Fundamental Growth Index's 0.47% returns. Long positions and hedges, and short positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, please check the Strategy's top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Grow Funds highlighted Buda Juice, Inc. (NYSEAMERICAN: BUDA ). Buda Juice, Inc. (NYSEAMERICAN:BUDA) is a US-based food company specializes in producing and distributing juice, lemonades, limeades, and wellness shots. On June 22, 2026, Buda Juice, Inc. (NYSEAMERICAN:BUDA) closed at $8.01 per share. One-month return of Buda Juice, Inc. (NYSEAMERICAN:BUDA) was -5.66%, and its shares lost 15.42% over the past three months. Buda Juice, Inc. (NYSEAMERICAN:BUDA) has a market capitalization of $100.66 million.
Grow Funds stated the following regarding Buda Juice, Inc. (NYSEAMERICAN:BUDA) in its Q1 2026 investor letter:
"Buda Juice, Inc.(NYSEAMERICAN:BUDA) produces and distributes beverages made from organic fruits and vegetables. The company bridges the gap between shelf-stable products and operationally challenging in-store juicing. The product assortment includes juices, lemonades, limeades, and wellness shots. Buda Juice is known for no pasteurization, preservatives, GMOs, or artificial ingredients and is sold in the fresh department in supermarkets. In short, BUDA is creating a new ultra-fresh category within the supermarket. All products are produced and delivered in a continuous 35-degree Fahrenheit cold chain from farm to fridge. Currently, BUDA is produced and distributed in only Texas supermarkets including Costco, HEB, and Kroger. Last year, they generated about $12 million in annual revenue and $3.6 million in net income. The company is in the process of expanding capacity in Texas to $55 million by adding additional production lines. We believe Buda can be a $25 stock as the company executes just within Texas.
We anticipate BUDA adding additional production and distribution locations in the Southeast U.S. and Southwest U.S. in the next 2 years, giving them capacity for up to $165 million in annual revenue. We believe Buda will be able to fill this expanded capacity with current and future retailer wins, none of which have fully scaled..." ( Click here to read the full text )
davidsansegundo/Shutterstock.com
Buda Juice, Inc. (NYSEAMERICAN:BUDA) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 . According to our database, one hedge fund portfolios held Buda Juice, Inc. (NYSEAMERICAN:BUDA) at the end of the first quarter, compared to 0 in the previous quarter. While we acknowledge the potential of Buda Juice, Inc. (NYSEAMERICAN:BUDA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years .
Disclosure: None. This article is originally published at Insider Monkey .
